These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 15090474

  • 1. Multiple sclerosis: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo.
    Weber MS, Starck M, Wagenpfeil S, Meinl E, Hohlfeld R, Farina C.
    Brain; 2004 Jun; 127(Pt 6):1370-8. PubMed ID: 15090474
    [Abstract] [Full Text] [Related]

  • 2. Distinct responses of monocytes to Toll-like receptor ligands and inflammatory cytokines.
    Farina C, Theil D, Semlinger B, Hohlfeld R, Meinl E.
    Int Immunol; 2004 Jun; 16(6):799-809. PubMed ID: 15096475
    [Abstract] [Full Text] [Related]

  • 3. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
    Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N, Akashi S, Miyake K, Godowski PJ, Makino H.
    Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
    [Abstract] [Full Text] [Related]

  • 4. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.
    Skinner NA, MacIsaac CM, Hamilton JA, Visvanathan K.
    Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191
    [Abstract] [Full Text] [Related]

  • 5. Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b.
    Jensen MA, Yanowitch RN, Reder AT, White DM, Arnason BG.
    Mult Scler; 2010 Jan; 16(1):30-8. PubMed ID: 20007427
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Failure of glatiramer acetate to modify the peripheral T cell repertoire of relapsing-remitting multiple sclerosis patients.
    Berthelot L, Miqueu P, Pettré S, Guillet M, Moynard J, Wiertlewski S, Lefrère F, Brouard S, Soulillou JP, Laplaud DA.
    Clin Immunol; 2010 Apr; 135(1):33-42. PubMed ID: 20116333
    [Abstract] [Full Text] [Related]

  • 9. Altered biliary epithelial cell and monocyte responses to lipopolysaccharide as a TLR ligand in patients with primary biliary cirrhosis.
    Zhao J, Zhao S, Zhou G, Liang L, Guo X, Mao P, Zhou X, Wang H, Nan Y, Xu D, Yu J.
    Scand J Gastroenterol; 2011 Apr; 46(4):485-94. PubMed ID: 21275501
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression of urokinase plasminogen activator receptor on monocytes from patients with relapsing-remitting multiple sclerosis: effect of glatiramer acetate (copolymer 1).
    Balabanov R, Lisak D, Beaumont T, Lisak RP, Dore-Duffy P.
    Clin Diagn Lab Immunol; 2001 Nov; 8(6):1196-203. PubMed ID: 11687463
    [Abstract] [Full Text] [Related]

  • 12. Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis.
    Caragnano M, Tortorella P, Bergami A, Ruggieri M, Livrea P, Specchio LM, Martino G, Trojano M, Furlan R, Avolio C.
    J Neuroimmunol; 2012 Apr; 245(1-2):93-7. PubMed ID: 22370183
    [Abstract] [Full Text] [Related]

  • 13. Blocking effects of serum reactive antibodies induced by glatiramer acetate treatment in multiple sclerosis.
    Salama HH, Hong J, Zang YC, El-Mongui A, Zhang J.
    Brain; 2003 Dec; 126(Pt 12):2638-47. PubMed ID: 12937077
    [Abstract] [Full Text] [Related]

  • 14. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M, Schreiner B, Kieseier BC, Neuhaus O, Dichgans J, Hartung HP, Weller M, Wiendl H.
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [Abstract] [Full Text] [Related]

  • 15. Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor.
    Ziemssen T, Kümpfel T, Klinkert WE, Neuhaus O, Hohlfeld R.
    Brain; 2002 Nov; 125(Pt 11):2381-91. PubMed ID: 12390966
    [Abstract] [Full Text] [Related]

  • 16. Selective developmental defects of cord blood antigen-presenting cell subsets.
    Drohan L, Harding JJ, Holm B, Cordoba-Tongson E, Dekker CL, Holmes T, Maecker H, Mellins ED.
    Hum Immunol; 2004 Nov; 65(11):1356-69. PubMed ID: 15556686
    [Abstract] [Full Text] [Related]

  • 17. Glatiramer acetate treatment normalized the monocyte activation profile in MS patients to that of healthy controls.
    Chuluundorj D, Harding SA, Abernethy D, La Flamme AC.
    Immunol Cell Biol; 2017 Mar; 95(3):297-305. PubMed ID: 27694998
    [Abstract] [Full Text] [Related]

  • 18. Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.
    Ruggieri M, Pica C, Lia A, Zimatore GB, Modesto M, Di Liddo E, Specchio LM, Livrea P, Trojano M, Avolio C.
    J Neuroimmunol; 2008 Jul 15; 197(2):140-6. PubMed ID: 18555539
    [Abstract] [Full Text] [Related]

  • 19. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B, Mitsdoerffer M, Kieseier BC, Chen L, Hartung HP, Weller M, Wiendl H.
    J Neuroimmunol; 2004 Oct 15; 155(1-2):172-82. PubMed ID: 15342209
    [Abstract] [Full Text] [Related]

  • 20. Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis.
    Sellebjerg F, Hesse D, Limborg S, Lund H, Søndergaard HB, Krakauer M, Sørensen PS.
    Mult Scler; 2013 Feb 15; 19(2):179-87. PubMed ID: 22653658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.